from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1452c/PE_PGRS28

LFCtreatmentdescriptionclass of inhibitor

0.600

Amikacinug/mL Amikacintranslation

-1.012

Cap5-10ug/mL Capreomycintranslation

-0.076

Rox10-50 ug/mL Roxithromycintranslation

-0.175

SM2-5 ug/mL Streptomycintranslation

0.122

Tet5-10 ug/mL Tetracyclinetranslation

-1.479

Rif0.2-5ug/mL Rifampicintranscription

-2.750

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.093

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.003

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.240

CPZ10-50 ug/mL Chlorpromazinerespiration

0.631

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.030

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.654

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.552

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.128

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.221

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.256

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.279

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.483

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.118

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.526

KCN5-20 ug/mL Potassium cyaniderespiration

0.384

NaN30.2-2 mM Sodium aziderespiration

-0.832

Nigericin50 uM Nigericinrespiration

-0.624

TRC10-150 ug/mL Triclosanrespiration

0.539

TRZ10-25 ug/mL Thioridazinerespiration

-0.162

Valinomycin0.5-10 uM Valinomycinrespiration

-0.939

ZnSO42 mM ZnSO4respiration

-1.144

menadione6-10 ug/mL Menadionerespiration

0.316

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.678

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.313

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.655

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.454

NRP_1Non-replicating persistence stage 1dosRassociated

-0.149

Amp0.2mg/mL AmpicillincellWall

-0.045

Cephalexin20-100 ug/mL CephalexincellWall

-1.223

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.366

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.057

EMB10-20 ug/mL EthambutolcellWall

-0.839

Eta12-40 ug/mL EthionamidecellWall

0.026

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.777

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.648

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.138

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.082

BZA0.12 mg/mL BenzamidearomaticAmides

0.380

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.180

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.208

H2O24 mM hydrogen peroxideDNAdamaging

-0.110

Levo10 ug/mL LevofloxacinDNAdamaging

0.308

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.174

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.256

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.429

UVUV-irradiationDNAdamaging

0.873

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.249

Antimycin12.5-50 ug/mL Antimycin A?

-1.366

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.180

PA_110-50 ug/mL Antitubercular compound PA-1?

0.289

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.253

PA8240.2-2 ug/mL PA-824?

0.539

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.423

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.941

Verapamil50 uM Verapamil?

-1.131

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.304

methoxatin10-20 ug/mL Methoxatin?